Biography
Carin A. Uyl-de Groot studied Health Care Policy and Management at the Erasmus University Rotterdam. From March 1990 onwards she is working at the institute for Medical Technology Assessment/Department of Health Care Policy and Management at the Erasmus Medical Centre Rotterdam. Her research activities are mainly focused on cost-effectiveness analyses of cancer treatments. Quality of life studies are an integral part of these studies. From 1994 she is program leader of cancer studies. Her main interest consists of diagnostics and therapeutic technologies, economic studies linked to clinical studies, modelling studies, cost studies, quality of life studies, methodological issues and implementation studies particularly in the cancer field. She got her PhD in 1995. Since March 2000 she is director of the institute for Medical Technology Assessment. Since November 2005 she has been appointed professor of health technology assessment at the VU University Medical Center in Amsterdam.
Erasmus School of Health Policy & Management
Full professor | Health Technology Assessment (HTA)
- uyl@eshpm.eur.nl
More information
Work
- Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl-de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Marye J. Boers-Sonderen, Alfons J.M. van den Eertwegh, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Olivier J. van Not, Astrid A.M. van der Veldt, Karijn P.M. Suijkerbuijk & Margreet G. Franken (2025) - Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model - European Journal of Cancer, 218 - doi: 10.1016/j.ejca.2024.115071 - [link]
- Yi Hsuan Chen, Michiel Kroesen, Mischa Hoogeman, Matthijs Versteegh, Carin Uyl-de Groot & Hedwig M. Blommestein (2025) - Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study - Clinical and Translational Radiation Oncology, 51 - doi: 10.1016/j.ctro.2025.100913 - [link]
- Elaine Julian, Tom Belleman, Maria João Garcia, Robin Doeswijk, Rosa Giuliani, Bernhard J. Woermann, Daniel Widmer, Patrick Tilleul, Ruben Casado-Arroyo, Valentina Strammiello, Kate Morgan, Marcus Guardian, Michael Ermisch, Renato Bernardini, Fabrizio Gianfrate, Stefano Capri, Carin de Groot, Mira Pavlovic, Jörg Ruof & Maureen van Molken (2025) - Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy - Journal of Market Access and Health Policy, 5, 1-16
- Tom Belleman, Jeroen van Wijngaarden, Malou C.P. Kuppen, Saskia de Groot, Kim J. M. van der Velden, Dianne Bosch, Inge M. van Oort, Carin Uyl - de Groot & Welmoed van Deen (2025) - Moving from a registry to a learning health system: A casestudy of a Dutch prostate cancer registry - Learning Health Systems - doi: 10.1002/lrh2.10476 - [link]
- Nicole Huang, Laura A Hatfield, Saeed Al-Azazi, Pieter Bakx, Amitava Banerjee, Nitzan Burrack, Yu Chin Chen, Christina Fu, Carlos Godoy Junior, Renaud Heine, Dennis T. Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Bheeshma Ravi, Therese A Stukel, Carin de Groot, Peter Cram & Bruce E. Landon (2024) - Comparison of Management and Outcomes of Hip Fractures Among Low- and High-Income Patients in Six High-Income Countries - Journal of General Internal Medicine - doi: 10.1007/s11606-024-09274-9
- Michiel Zietse, Ruben Malmberg, Roelof W.F. van Leeuwen, Frederick W. Thielen & Carin A. Uyl – de Groot (2024) - The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspective - Bmc Health Services Research, 24 (1) - doi: 10.1186/s12913-024-11719-0 - [link]
- Minka Zivkovic, , , Elisabeth Pols - van Veen, Vossa van der Vegte, Silvie A.E. Sebastian, Annick S. de Moor, Suzanne J.A. Korporaal, Roger Schutgens, Rolf T. Urbanus, Gerard Jansen, Wala Al Arashi, Ryanne Arisz, Ruben Bierings, Johan Boender, Martijn Brands, Annelien Bredenoord, Laura Bukkems, Lex Burdorf, Marjon Cnossen, Tine Goedhart, Jan Hazelzet, Elise Huisman, Nathalie Jansen, Marieke Kruip, Sebastiaan Laan, Frank Leebeek, Nikki van Leeuwen, Hester Lingsma, Moniek de Maat, Karina Meijer, Iris van Moort, Caroline Mussert, Suzanne Polinder, Simone Reitsma, Lorenzo Romano, Saskia Schols & Carin Uyl (2024) - Functional characterization of a nanobody-based glycoprotein VI-specific platelet agonist - Research and Practice in Thrombosis and Haemostasis, 8 (7) - doi: 10.1016/j.rpth.2024.102582 - [link]
- Renaud J.S.D. Heine, Ron H.J. Mathijssen, Floor A.J. Verbeek, Chantal Van Gils & Carin A. Uyl-de Groot (2024) - Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands - Value in Health, 27 (10), 1367-1372 - doi: 10.1016/j.jval.2024.06.003 - [link]
- N. S.H. Xander, B. Leeneman, A. M.C. Dingemans, W. E. Fiets, W. K. de Jong, N. E.M. Uyl, A. N.M. Wymenga, A. K.L. Reyners & C. A. Uyl-de Groot (2024) - Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not? - European Journal of Cancer, 209 - doi: 10.1016/j.ejca.2024.114262 - [link]
- Sebastiaan N.J. Laan, Suzan de Boer, , Richard J. Dirven, Iris van Moort, Thomas B. Kuipers, Hailiang Mei, Ruben Bierings, Jeroen Eikenboom, Martijn Brands, Sjoerd Koopman, Laura Bukkems, Michael Cloesmeijer, Alexander Janssen, Karin Fijnvandraat, Samantha Gouw, Ron Mathôt, Lotte Haverman, Emile van den Akker, Maartje van den Biggelaar, Masja de Haas, Sander Meijer, Jan Voorberg, Jessica Del Castillo Alferez, Huan Zhang, Johan Boender, Stephan Meijer, Karina Meijer, Sean de Jong, Sebastiaan N.J. Laan, Saskia Schols, Lex Burdorf, Marjon Cnossen, Jan Hazelzet, Elise Huisman, Marieke Kruip, Frank Leebeek, Nikki van Leeuwen, Hester Lingsma, Moniek de Maat, Suzanne Polinder, Simone Reitsma, Ryanne Arisz, Lorenzo Romano, Wala Al Arashi, Shannon van Hoorn, Tine Goedhart, Carin Uyl, Nathalie Jansen, Minka Zivkovic & Annelien Bredenoord (2024) - Transcriptional and functional profiling identifies inflammation and endothelial-to-mesenchymal transition as potential drivers for phenotypic heterogeneity within a cohort of endothelial colony forming cells - Journal of Thrombosis and Haemostasis, 22 (7), 2027-2038 - doi: 10.1016/j.jtha.2024.03.018 - [link]
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
Cie Beoordeling Oncologische Middelen
- Start date approval
- juli 2022
- End date approval
- juli 2025
- Place
- UTRECHT
Gezondheidsraad
- Start date approval
- juli 2022
- End date approval
- juli 2025
- Place
- DEN HAAG
bestuurslid CPO, Erasmus Medisch Centrum
- Start date approval
- juli 2022
- End date approval
- juli 2025
- Place
- ONBEKEND
Module Knowledge
- Level
- bachelor 1
- Year Level
- bachelor 1
- Year
- 2024
- Course Code
- GW114K
Master Thesis Eu-HEM
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4560M
Master Thesis HE
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
